117 related articles for article (PubMed ID: 15880573)
1. Lactase persistence and ovarian carcinoma risk in Finland, Poland and Sweden.
Kuokkanen M; Butzow R; Rasinperä H; Medrek K; Nilbert M; Malander S; Lubinski J; Järvelä I
Int J Cancer; 2005 Oct; 117(1):90-4. PubMed ID: 15880573
[TBL] [Abstract][Full Text] [Related]
2. Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland.
Torniainen S; Hedelin M; Autio V; Rasinperä H; Bälter KA; Klint A; Bellocco R; Wiklund F; Stattin P; Ikonen T; Tammela TL; Schleutker J; Grönberg H; Järvelä I
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):956-61. PubMed ID: 17507622
[TBL] [Abstract][Full Text] [Related]
3. The C/C-13910 genotype of adult-type hypolactasia is associated with an increased risk of colorectal cancer in the Finnish population.
Rasinperä H; Forsblom C; Enattah NS; Halonen P; Salo K; Victorzon M; Mecklin JP; Järvinen H; Enholm S; Sellick G; Alazzouzi H; Houlston R; Robinson J; Groop PH; Tomlinson I; Schwartz S; Aaltonen LA; Järvelä I;
Gut; 2005 May; 54(5):643-7. PubMed ID: 15831909
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
5. BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk.
Auranen A; Spurdle AB; Chen X; Lipscombe J; Purdie DM; Hopper JL; Green A; Healey CS; Redman K; Dunning AM; Pharoah PD; Easton DF; Ponder BA; Chenevix-Trench G; Novik KL
Int J Cancer; 2003 Jan; 103(3):427-30. PubMed ID: 12471628
[TBL] [Abstract][Full Text] [Related]
6. Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer.
Baxter SW; Choong DY; Campbell IG
Cancer Lett; 2002 Mar; 177(1):75-81. PubMed ID: 11809533
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
[TBL] [Abstract][Full Text] [Related]
8. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene Rearrangement.
Tang S; Yang F; Du X; Lu Y; Zhang L; Zhou X
Int J Gynecol Pathol; 2016 Jul; 35(4):337-47. PubMed ID: 27271776
[TBL] [Abstract][Full Text] [Related]
10. The genetic variant of lactase persistence C (-13910) T as a risk factor for type I and II diabetes in the Finnish population.
Enattah NS; Forsblom C; Rasinperä H; Tuomi T; Groop PH; Järvelä I;
Eur J Clin Nutr; 2004 Sep; 58(9):1319-22. PubMed ID: 15054412
[TBL] [Abstract][Full Text] [Related]
11. Genetic variant of lactase-persistent C/T-13910 is associated with bone fractures in very old age.
Enattah NS; Sulkava R; Halonen P; Kontula K; Järvelä I
J Am Geriatr Soc; 2005 Jan; 53(1):79-82. PubMed ID: 15667380
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
[TBL] [Abstract][Full Text] [Related]
13. [Relation Between microsomal epoxide hydrolase polymorphism and susceptibility to ovarian epithelial cancer].
Kang S; Duan LH; Li Y; Song JF; Zhang JH
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):556-7. PubMed ID: 15363360
[No Abstract] [Full Text] [Related]
14. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
15. p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China.
Yan L; Na W; Shan K; Xiao-Wei M; Wei G; Shu-Cheng C
Int J Gynecol Cancer; 2008; 18(1):30-5. PubMed ID: 17466040
[TBL] [Abstract][Full Text] [Related]
16. [Endometriosis as a risk factor for ovarian cancer].
Vargas-Hernández VM
Cir Cir; 2013; 81(2):163-8. PubMed ID: 23522320
[TBL] [Abstract][Full Text] [Related]
17. Biology of epithelial ovarian cancer: implications for screening women at high genetic risk.
Hogg R; Friedlander M
J Clin Oncol; 2004 Apr; 22(7):1315-27. PubMed ID: 15051780
[TBL] [Abstract][Full Text] [Related]
18. Familial invasive and borderline ovarian tumors by proband status, age and histology.
Hemminki K; Granström C
Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921
[TBL] [Abstract][Full Text] [Related]
19. Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
Goodman MT; Tung KH; McDuffie K; Wilkens LR; Donlon TA
Nutr Cancer; 2003; 46(1):23-9. PubMed ID: 12925300
[TBL] [Abstract][Full Text] [Related]
20. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.
Hefler LA; Grimm C; Ackermann S; Malur S; Radjabi-Rahat AR; Leodolter S; Beckmann MW; Zeillinger R; Koelbl H; Tempfer CB
Cancer Res; 2003 Jun; 63(12):3066-8. PubMed ID: 12810629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
